ABT (STOCKS)
Abbott Laboratories
$100.310000
+0.010000 (+0.01%)
Prev close: $100.300000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert B. Ford
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $175,298.08M
- Employees
- 114,000
- P/E (TTM)
- 26.97
- P/B (TTM)
- 3.34
- Dividend Yield
- 239.28%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
16
Buy
9
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.50 | $1.51 | -0.0113 | -0.75% |
|
Sep 2025 (Q3)
|
$1.30 | $1.31 | -0.0139 | -1.06% |
|
Jun 2025 (Q2)
|
$1.26 | $1.27 | -0.0074 | -0.58% |
|
Mar 2025 (Q1)
|
$1.09 | $1.08 | +0.0079 | +0.73% |
Financial Statements
| Revenues | $44.33B |
| Benefits Costs and Expenses | $35.86B |
| Cost Of Revenue | $19.32B |
| Costs And Expenses | $36.28B |
| Gross Profit | $25.01B |
| Operating Expenses | $16.96B |
| Selling, General, and Administrative Expenses | $12.33B |
| Research and Development | $2.94B |
| Other Operating Expenses | $1.68B |
| Operating Income/Loss | $8.05B |
| Income/Loss From Continuing Operations After Tax | $6.52B |
| Income/Loss From Continuing Operations Before Tax | $8.47B |
| Income Tax Expense/Benefit | $1.94B |
| Income Tax Expense/Benefit, Current | $1.50B |
| Income Tax Expense/Benefit, Deferred | $441.00M |
| Net Income/Loss | $6.52B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $6.52B |
| Net Income/Loss Available To Common Stockholders, Basic | $6.50B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $24.00M |
| Preferred Stock Dividends And Other Adjustments | $24.00M |
| Basic Earnings Per Share | $3.73 |
| Diluted Earnings Per Share | $3.72 |
| Basic Average Shares | 1,741,000,000 |
| Diluted Average Shares | 1,748,000,000 |
| Assets | $86.71B |
| Current Assets | $26.00B |
| Inventory | $6.49B |
| Other Current Assets | $19.51B |
| Noncurrent Assets | $60.72B |
| Fixed Assets | $11.82B |
| Intangible Assets | $5.53B |
| Other Non-current Assets | $43.38B |
| Liabilities | $33.94B |
| Current Liabilities | $16.50B |
| Wages | $1.75B |
| Other Current Liabilities | $14.75B |
| Noncurrent Liabilities | $17.45B |
| Long-term Debt | $12.93B |
| Other Non-current Liabilities | $4.52B |
| Equity | $52.77B |
| Equity Attributable To Noncontrolling Interest | $641.00M |
| Equity Attributable To Parent | $52.13B |
| Liabilities And Equity | $86.71B |
| Net Cash Flow From Operating Activities | $9.57B |
| Net Cash Flow From Operating Activities, Continuing | $9.57B |
| Net Cash Flow From Investing Activities | -$2.42B |
| Net Cash Flow From Investing Activities, Continuing | -$2.42B |
| Net Cash Flow From Financing Activities | -$6.31B |
| Net Cash Flow From Financing Activities, Continuing | -$6.31B |
| Net Cash Flow | $835.00M |
| Net Cash Flow, Continuing | $835.00M |
| Comprehensive Income/Loss | $8.43B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $8.43B |
| Other Comprehensive Income/Loss | $8.43B |
| Other Comprehensive Income/Loss Attributable To Parent | $1.91B |